| 2026-07-28 16:50 |
8-K |
["5.07", "8.01"] |
other |
0.15
|
Stockholder meeting to amend charter bylaws; unrelated to M&A activity. |
SEC · detail |
| 2026-07-22 16:05 |
8-K |
["1.01", "7.01", "9.01"] |
material agreement |
0.05
|
Product development and IIT collaboration agreement with Chinese biotech partner; no M&A signal. |
SEC · detail |
| 2026-06-22 20:22 |
8-K |
["5.07"] |
other |
0.05
|
Routine stockholder meeting on warrant exercise approvals; no M&A indicators. |
SEC · detail |
| 2026-06-04 17:00 |
8-K |
["5.02"] |
officer change |
0.35
|
CFO departure and board appointments; weak M&A signal without strategic review language. |
SEC · detail |
| 2026-06-01 19:13 |
8-K |
["1.01", "3.02", "9.01"] |
other |
0.05
|
Warrant exercise and equity financing transaction; no M&A indicators present. |
SEC · detail |
| 2026-05-29 17:01 |
8-K |
["5.02"] |
officer change |
0.15
|
Board director resignation with separation agreement; no M&A indicators present. |
SEC · detail |
| 2026-05-22 17:28 |
8-K |
["3.01", "5.02"] |
other |
0.15
|
Delisting notice and director resignations; no M&A signals, only regulatory compliance issues. |
SEC · detail |
| 2026-05-22 17:05 |
8-K |
["5.02"] |
officer change |
0.52
|
Three board members resigned on same date with separation agreements; weak M&A signal without explicit transaction language. |
SEC · detail |
| 2026-05-14 16:28 |
8-K |
["2.02", "9.01"] |
other |
0.05
|
Routine quarterly earnings announcement with no M&A-related content or signals. |
SEC · detail |
| 2026-05-06 07:45 |
8-K |
["7.01", "8.01", "9.01"] |
other |
0.05
|
Routine disclosure of corporate presentation and clinical update at medical conference; no M&A signals. |
SEC · detail |